Inventor · disambiguated record
Jun Liang
Also filed as: LIANG JUN · LIANG JUN F · Liang jun-xiang
63 granted patents·50 pending applications·361 citations·filing 2002–2025
98Inventor score
Top patents by PatentIndex Score
113 records- 0197US9980947B2Tetrahydro-pyrido[3,4-b]indole estrogen receptor modulators and uses thereofGENENTECH INC·Filed 2015·Granted May 29, 2018·17 cites·87 claims
- 0297US8063050B2Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitorsMITCHELL IAN S·Filed 2007·Granted Nov 22, 2011·63 cites·103 claims
- 0396US11337906B2Hair care and conditioning compositionsOREAL·Filed 2019·Granted May 24, 2022·12 cites·16 claims
- 0495US11566003B2Isoquinolines as inhibitors of HPK1GENENTECH INC·Filed 2020·Granted Jan 31, 2023·4 cites·31 claims
- 0595US8003651B2Pyrimidyl cyclopentanes as AKT protein kinase inhibitorsARRAY BIOPHARMA INC·Filed 2007·Granted Aug 23, 2011·35 cites·76 claims
- 0694US8853199B2Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitorsMITCHELL IAN S·Filed 2011·Granted Oct 7, 2014·20 cites·33 claims
- 0793US7589068B2Inhibitors of Akt activityMERCK & CO INC·Filed 2006·Granted Sep 15, 2009·16 cites·5 claims
- 0892US10966963B2Tetrahydro-pyrido[3,4-b]indole estrogen receptor modulators and uses thereofGENENTECH INC·Filed 2018·Granted Apr 6, 2021·10 cites·32 claims
- 0992US9845291B2Estrogen receptor modulators and uses thereofGENENTECH INC·Filed 2015·Granted Dec 19, 2017·15 cites·14 claims
- 1090US10407424B2Naphthyridines as inhibitors of HPK1GENENTECH INC·Filed 2018·Granted Sep 10, 2019·5 cites·72 claims
- 1190US9359340B2Hydroxylated and methoxylated pyrimidyl cyclopentanes as Akt protein kinase inhibitorsARRAY BIOPHARMA INC·Filed 2014·Granted Jun 7, 2016·9 cites·101 claims
- 1289US8377937B2Pyrimidyl cyclopentanes as AKT protein kinase inhibitorsARRAY BIOPHARMA INC·Filed 2008·Granted Feb 19, 2013·15 cites·37 claims
- 1388US8846681B2Pyrimidyl cyclopentanes as AKT protein kinase inhibitorsMITCHELL IAN S·Filed 2011·Granted Sep 30, 2014·11 cites·91 claims
- 1488US8486950B2Janus kinase inhibitor compounds and methodsGOODACRE SIMON CHARLES·Filed 2010·Granted Jul 16, 2013·25 cites·19 claims
- 1587US8329709B25H-cyclopenta[D]pyrimidines as AKT protein kinase inhibitorsBANKA ANNA L·Filed 2009·Granted Dec 11, 2012·10 cites·33 claims
- 1687US7544677B2Inhibitors of Akt activityMERCK & CO INC·Filed 2005·Granted Jun 9, 2009·13 cites·7 claims
- 1786US2025114338A1TETRAHYDRO-PYRIDO[3,4-b]INDOLE ESTROGEN RECEPTOR MODULATORS AND USES THEREOFGENENTECH INC·Filed 2024·Application pending·0 cites
- 1885US11058618B1Hair treatment compositionsOREAL·Filed 2020·Granted Jul 13, 2021·1 cites·11 claims
- 1984US12343411B2Compositions and methods for treating keratinous substratesOREAL·Filed 2020·Granted Jul 1, 2025·1 cites·20 claims
- 2083US10654867B2Heteroaryl estrogen receptor modulators and uses thereofGENENTECH INC·Filed 2019·Granted May 19, 2020·1 cites·5 claims
- 2183US8008317B2Inhibitors of akt activtiyMERCK SHARP & DOHME·Filed 2006·Granted Aug 30, 2011·9 cites·4 claims
- 2282US8618097B2Pyrimidyl cyclopentanes as AKT protein kinase inhibitorsBENCSIK JOSEF·Filed 2008·Granted Dec 31, 2013·7 cites·48 claims
- 2382US8609687B2Triazolopyridine JAK inhibitor compounds and methodsZHU BING-YAN·Filed 2012·Granted Dec 17, 2013·7 cites·45 claims
- 2482US7741453B2Long lasting fusion peptide inhibitors for HIV infectionCONJUCHEM BIOTECHNOLOGIES INC·Filed 2002·Granted Jun 22, 2010·19 cites·73 claims
- 2581US11034692B1Naphthyridines as inhibitors of HPK1GENENTECH INC·Filed 2019·Granted Jun 15, 2021·1 cites·20 claims
- 2681US9309240B2Pyrazolopyridine compounds, compositions and methods of useHOFFMANN LA ROCHE·Filed 2013·Granted Apr 12, 2016·6 cites·16 claims
- 2780US11612606B28-aminoisoquinoline compounds and uses thereofGENENTECH INC·Filed 2019·Granted Mar 28, 2023·2 cites·29 claims
- 2879US9505767B2Pyrazolo[1,5-A]pyrimidin-7(4H)-onehistone demethylase inhibitorsGENENTECH INC·Filed 2014·Granted Nov 29, 2016·4 cites·3 claims
- 2977US10053451B2Heterocyclic estrogen receptor modulators and uses thereofGENENTECH INC·Filed 2016·Granted Aug 21, 2018·2 cites·10 claims
- 3077US8853216B2Hydroxylated pyrimidyl cyclopentane as AKT protein kinase inhibitorBENCSIK JOSEF·Filed 2009·Granted Oct 7, 2014·3 cites·5 claims
- 3177US7910561B2Inhibitors of Akt activityMERCK SHARP & DOHME·Filed 2005·Granted Mar 22, 2011·3 cites·4 claims
- 3277US2022226326A1Hydroxylated and methoxylated pyrimidyl cyclopentanes as akt protein kinase inhibitorsARRAY BIOPHARMA INC·Filed 2021·Application pending·0 cites
- 3377US2025152588A1Hydroxylated and methoxylated pyrimidyl cyclopentanes as akt protein kinase inhibitorsARRAY BIOPHARMA INC·Filed 2025·Application pending·0 cites
- 3475US8846683B2Pyrimidyl cyclopentanes as Akt protein kinase inhibitorsARRAY BIOPHARMA INC·Filed 2013·Granted Sep 30, 2014·1 cites·35 claims
- 3574US12268769B2Hair coloring compositionsOREAL·Filed 2023·Granted Apr 8, 2025·0 cites·20 claims
- 3674US8697708B2Azabenzothiazole compounds, compositions and methods of useBLENCH TOBY JONATHAN·Filed 2011·Granted Apr 15, 2014·3 cites·1 claims
- 3773US9409886B2Pyrimidyl cyclopentanes as AKT protein kinase inhibitorsARRAY BIOPHARMA INC·Filed 2013·Granted Aug 9, 2016·2 cites·50 claims
- 3872US12233052B2Tetrahydro-pyrido[3,4-b]indole estrogen receptor modulators and uses thereofGENENTECH INC·Filed 2021·Granted Feb 25, 2025·0 cites·32 claims
- 3972US8828215B2Process for producing a coating on the surface of a substrate based on lightweight metals by plasma-electrolytic oxidationBLAWERT CARSTEN·Filed 2012·Granted Sep 9, 2014·3 cites·12 claims
- 4071US8895566B25H-cyclopenta[d]pyrimidines as AKT protein kinase inhibitorsARRAY BIOPHARMA INC·Filed 2012·Granted Nov 25, 2014·1 cites·34 claims
- 4171US8835434B2Hydroxylated pyrimidyl cyclopentanes as akt protein kinase inhibitorsBENCSIK JOSEF R·Filed 2009·Granted Sep 16, 2014·2 cites·2 claims
- 4271US2020345735A1Hydroxylated and methoxylated pyrimidyl cyclopentanes as akt protein kinase inhibitorsARRAY BIOPHARMA INC·Filed 2020·Application pending·0 cites
- 4371US2021378931A1Cosmetic compositionsOREAL·Filed 2021·Application pending·0 cites
- 4470US2025230147A1Lactams as cbl-b inhibitorsGENENTECH INC·Filed 2024·Application pending·0 cites
- 4569US10399939B2Tetrahydronaphthalene estrogen receptor modulators and uses thereofGENENTECH INC·Filed 2016·Granted Sep 3, 2019·1 cites·35 claims
- 4669US9434732B2Triazolopyridine JAK inhibitor compounds and methodsGENENTECH INC·Filed 2013·Granted Sep 6, 2016·1 cites·46 claims
- 4768US10035801B2Pyrazolo compounds and uses thereofCONSTELLATION PHARMACEUTICALS INC·Filed 2014·Granted Jul 31, 2018·1 cites·15 claims
- 4867US2025127697A1Hair treatment composition with cationic surfactant, fatty alcohols, and low polar oilOREAL·Filed 2023·Application pending·0 cites
- 4966US2022332718A1PYRAZOLO[1,5a]PYRIMIDINE DERIVATIVES AS IRAK4 MODULATORSGENENTECH INC·Filed 2021·Application pending·0 cites
- 5065US2025009621A1Anhydrous hair treatment composition comprising alpha hydroxy acid esterOREAL·Filed 2023·Application pending·0 cites
Showing the top 50 of 113 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Jun Liang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →